ifosfamide and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ifosfamide has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bowman, E; Coskun, O; Gendelman, HE; Laurie, C; Mosley, RL; Reynolds, A	1

Other Studies

1 other study(ies) available for ifosfamide and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Journal of neuroimmunology, 2007, Volume: 183, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glatiramer Acetate; Ifosfamide; Male; Mice; Mitomycin; Neurons; Parkinson Disease, Secondary; Peptides; Substantia Nigra; Tyrosine 3-Monooxygenase	2007

Article

Year

CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Journal of neuroimmunology, 2007, Volume: 183, Issue:1-2

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adoptive Transfer; Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glatiramer Acetate; Ifosfamide; Male; Mice; Mitomycin; Neurons; Parkinson Disease, Secondary; Peptides; Substantia Nigra; Tyrosine 3-Monooxygenase

2007